CRSP Financial Statements & Analysis
Complete financial statements for CRSP including income statement, balance sheet, and cash flow statement. Analyze CRSP's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).
Financial Health Score
Financial Health Score
Income Statement
Revenue
16.9% ↑
Net Income
2.2% ↑
Gross Margin
17.4% ↑
Operating Margin
17.2% ↑
Balance Sheet
Current Ratio
35.6% ↑
Debt to Equity
111.2% ↓
Asset Turnover
-2.9% ↓
Cash Flow
Operating Cash Flow
-15.9% ↓
Net Cash Flow
266.9% ↑
Free Cash Flow
-16.0% ↓
Cash Flow to Debt
41.9% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | TTM Q4 '25 | TTM Q1 '26 | Change | Impact |
|---|---|---|---|---|
| Revenue | 3.51M | 4.10M | 16.9% | |
| Gross Profit | -227.81M | -219.96M | 3.4% | |
| Operating Income | -568.32M | -550.14M | 3.2% | |
| Net Income | -581.60M | -568.53M | 2.2% | |
| EPS | -1.64 | -1.56 | 5.0% | |
| EBITDA | -558.53M | -546.16M | 2.2% | |
| Gross Margin | -6490.28% | -5360.86% | 17.4% | |
| Operating Margin | -16191.40% | -13408.29% | 17.2% | |
| Net Income Margin | -16569.77% | -13856.54% | 16.4% | |
| R&D Expenses | 274.55M | 270.63M | 1.4% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 |
|---|---|---|---|---|---|
| Revenue | 4.10M | 3.51M | 37.65M | — | — |
| Gross Profit | -219.96M | -227.81M | -134.31M | — | — |
| Operating Income | -550.14M | -568.32M | -478.14M | — | — |
| Net Income | -568.53M | -581.60M | -488.30M | — | — |
| EPS | -1.56 | -1.64 | -1.40 | — | — |
| EBITDA | -546.16M | -558.53M | -465.97M | — | — |
| Gross Margin | -5360.86% | -6490.28% | -356.77% | — | — |
| Operating Margin | -13408.29% | -16191.40% | -1270.10% | — | — |
| Net Income Margin | -13856.54% | -16569.77% | -1297.08% | — | — |
| R&D Expenses | 270.63M | 274.55M | 278.83M | — | — |
Financial Metrics
Want to dive deeper into CRSP's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics